These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 16783849)

  • 1. IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors.
    Belessi CJ; Davi FB; Stamatopoulos KE; Degano M; Andreou TM; Moreno C; Merle-Béral H; Crespo M; Laoutaris NP; Montserrat E; Caligaris-Cappio F; Anagnostopoulos AZ; Ghia P
    Eur J Immunol; 2006 Jul; 36(7):1963-74. PubMed ID: 16783849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
    Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine.
    Abramenko I; Bilous N; Kryachok I; Filonenko I; Pilipenko G; Chumak A; Bazyka D; Bebeshko V
    Exp Oncol; 2007 Sep; 29(3):226-30. PubMed ID: 18004251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a Northeastern region of Italy.
    Donisi PM; Di Lorenzo N; Riccardi M; Paparella A; Sarpellon C; Zupo S; Bertoldero G; Minotto C; Stracca-Pansa V
    Diagn Mol Pathol; 2006 Dec; 15(4):206-15. PubMed ID: 17122648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
    Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
    Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.
    Stamatopoulos K; Belessi C; Moreno C; Boudjograh M; Guida G; Smilevska T; Belhoul L; Stella S; Stavroyianni N; Crespo M; Hadzidimitriou A; Sutton L; Bosch F; Laoutaris N; Anagnostopoulos A; Montserrat E; Fassas A; Dighiero G; Caligaris-Cappio F; Merle-Béral H; Ghia P; Davi F
    Blood; 2007 Jan; 109(1):259-70. PubMed ID: 16985177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene.
    Ghia P; Stamatopoulos K; Belessi C; Moreno C; Stella S; Guida G; Michel A; Crespo M; Laoutaris N; Montserrat E; Anagnostopoulos A; Dighiero G; Fassas A; Caligaris-Cappio F; Davi F
    Blood; 2005 Feb; 105(4):1678-85. PubMed ID: 15466924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia.
    Mansouri MR; Sevov M; Aleskog A; Jondal M; Merup M; Sundström C; Osorio L; Rosenquist R
    Eur J Haematol; 2010 Feb; 84(2):109-16. PubMed ID: 19889012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia.
    Capello D; Guarini A; Berra E; Mauro FR; Rossi D; Ghia E; Cerri M; Logan J; Foà R; Gaidano G
    Leukemia; 2004 Dec; 18(12):1941-7. PubMed ID: 15483675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia.
    Duke VM; Gandini D; Sherrington PD; Lin K; Heelan B; Amlot P; Mehta AB; Hoffbrand AV; Foroni L
    Haematologica; 2003 Nov; 88(11):1259-71. PubMed ID: 14607755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.
    Smit LA; van Maldegem F; Langerak AW; van der Schoot CE; de Wit MJ; Bea S; Campo E; Bende RJ; van Noesel CJ
    Haematologica; 2006 Jul; 91(7):903-11. PubMed ID: 16818277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia.
    Stanganelli C; Travella A; Bezares R; Slavutsky I
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):447-457.e2. PubMed ID: 23665144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The origin of B-cell chronic lymphocytic leukemia.
    Ghia P; Caligaris-Cappio F
    Semin Oncol; 2006 Apr; 33(2):150-6. PubMed ID: 16616061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia.
    Mauerer K; Zahrieh D; Gorgun G; Li A; Zhou J; Ansén S; Rassenti LZ; Gribben JG
    Br J Haematol; 2005 May; 129(4):499-510. PubMed ID: 15877732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin heavy chain variable gene usage and (super)-antigen drive in chronic lymphocytic leukemia.
    Bühler A; Zenz T; Stilgenbauer S
    Clin Cancer Res; 2010 Jan; 16(2):373-5. PubMed ID: 20068107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage.
    Dal-Bo M; Del Giudice I; Bomben R; Capello D; Bertoni F; Forconi F; Laurenti L; Rossi D; Zucchetto A; Pozzato G; Marasca R; Efremov DG; Guarini A; Del Poeta G; Foà R; Gaidano G; Gattei V
    Br J Haematol; 2011 Apr; 153(1):3-14. PubMed ID: 21303354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of detectable somatic hypermutation in the V region of the Ig H chain gene of a human chronic B lymphocytic leukemia.
    Meeker TC; Grimaldi JC; O'Rourke R; Loeb J; Juliusson G; Einhorn S
    J Immunol; 1988 Dec; 141(11):3994-8. PubMed ID: 3141510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM-producing chronic lymphocytic leukemia cells undergo immunoglobulin isotype-switching without acquiring somatic mutations.
    Efremov DG; Ivanovski M; Batista FD; Pozzato G; Burrone OR
    J Clin Invest; 1996 Jul; 98(2):290-8. PubMed ID: 8755637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.